An open-label study of 80 patients with irritable bowel syndrome (IBS) found that those who knew they were receiving a placebo still experienced improvements, including reduced symptom severity, compared to those who did not receive any additional treatment. Read more at here.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder